Chiara Mele

Dr. Chiara Mele

Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CSCarolina Di somma
Carolina Di somma
ESElisabetta Scarano
Elisabetta Scarano
Luigi BarreaLuigi Barrea
Luigi Barrea
VZVolha V. Zhukouskaya
Volha V. Zhukouskaya
Silvia SavastanoSilvia Savastano
Silvia Savastano
PMPAOLO MARZULLO
PAOLO MARZULLO
Vitamin D system comprises hormone precursors, active metabolites, carriers, enzymes, and receptors involved in genomic and non-genomic effects. In addition to classical bone-related effects, this system has also been shown to activate multiple molecular mediators and elicit many physiological functions. In vitro and in vivo studies have, in fact, increasingly focused on the “non-calcemic” actions of vitamin D, which are associated with the maintenance of glucose homeostasis, cardiovascular morbidity, autoimmunity, inflammation, and cancer. In parallel, growing evidence has recognized that a multimodal association links vitamin D system to brain development, functions and diseases. With vitamin D deficiency reaching epidemic proportions worldwide, there is now concern that optimal levels of vitamin D in the bloodstream are also necessary to preserve the neurological development and protect the adult brain. The aim of this review is to highlight the relationship between vitamin D and neurological diseases.

12 April 2019 in International Journal of Obesity Supplements
Verified
Journal Article
Closed access
PDF file
SMSilvia Migliaccio
Silvia Migliaccio
ANAndrea Di Nisio
Andrea Di Nisio
CMChiara Mele
Chiara Mele
LSLorenzo Scappaticcio
Lorenzo Scappaticcio
SSSilvia Savastano
Silvia Savastano
ACAnnamaria Colao
Annamaria Colao

17 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Mattia BellanMattia Bellan
Mattia Bellan
LALaura ANDREOLI
Laura ANDREOLI
CMChiara Mele
Chiara Mele
PSPier Paolo Sainaghi
Pier Paolo Sainaghi
CRCristina Rigamonti
Cristina Rigamonti
PMPAOLO MARZULLO
PAOLO MARZULLO
Vitamin D is a pleiotropic secosteroid yielding multiple actions in human physiology. Besides the canonical regulatory activity on bone metabolism, several non-classical actions have been described and the ability of vitamin D to partake in the regulation of the immune system is particularly interesting, though far stronger and convincing evidence has been collected in in vitro as compared to in vivo studies. Whether vitamin D is able to regulate at physiological concentrations the human immune system remains unproven to date. Consequently, it is not established if vitamin D status is a factor involved in the pathogenesis of immune-mediated diseases and if cholecalciferol supplementation acts as an adjuvant for autoimmune diseases. The development of autoimmunity is a heterogeneous process, which may involve different organs and systems with a wide range of clinical implications. In the present paper, we reviewed the current evidences regarding vitamin D role in the pathogenesis and management of different autoimmune diseases.

25 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VPValeria Pingue
Valeria Pingue
CMChiara Mele
Chiara Mele
ANAntonio Nardone
Antonio Nardone
Post-traumatic seizures (PTS) are a common and debilitating complication of traumatic brain injury (TBI) and could have a harmful impact on the progress of patient rehabilitation. To assess the effect of PTS and relative therapy on outcome in the initial phase after TBI, during the rehabilitation process when neuroplasticity is at its highest, we retrospectively examined the clinical data of 341 adult patients undergoing rehabilitation for at least 6 months post-TBI in our neurorehabilitation unit between 2008 and 2019. We correlated through logistic regression the occurrence of seizures and use of anti-seizure medication (ASM) with neurological and functional outcomes, respectively assessed with the Glasgow Coma Scale (GCS) and the Functional Independence Measure (FIM). PTS were documented in 19.4% of patients: early PTS (EPTS) in 7.0%; late PTS (LPTS) in 9.4%; both types in 3.0%. Patients who developed EPTS had an increased risk of developing LPTS (OR = 3.90, CI 95% 1.58–9.63, p = 0.003). Patients with LPTS had a significantly higher risk of worse neurological (p < 0.0001) and rehabilitation (p < 0.05) outcome. Overall, 38.7% of patients underwent therapy with ASM; prophylactic therapy was prescribed in 24.0% of patients, of whom 14.6% subsequently developed seizures. Mortality was associated with a lower FIM and GCS score on admission but not significantly with PTS. The use of ASM was associated with a worse rehabilitation outcome, independently of the onset of epilepsy during treatment. LPTS appear to exert a negative impact on rehabilitation outcome and their occurrence is not reduced by prophylactic therapy, whereas EPTS do not influence outcome. Our findings caution against the generic use of prophylactic therapy to prevent post-traumatic epilepsy in patients with TBI.

16 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
CMChiara Mele
Chiara Mele
MCMarina Caputo
Marina Caputo
ABAlessandro Bisceglia
Alessandro Bisceglia
MSMaria Teresa Samà
Maria Teresa Samà
MZMarco Zavattaro
Marco Zavattaro
PMPAOLO MARZULLO
PAOLO MARZULLO
Vitamin D is a secosteroid with a pleiotropic role in multiple physiological processes. Besides the well-known activity on bone homeostasis, recent studies suggested a peculiar role of vitamin D in different non-skeletal pathways, including a key role in the modulation of immune responses. Recent evidences demonstrated that vitamin D acts on innate and adaptative immunity and seems to exert an immunomodulating action on autoimmune diseases and cancers. Several studies demonstrated a relationship between vitamin D deficiency, autoimmune thyroid disorders, and thyroid cancer. This review aims to summarize the evidences on the immunomodulatory effect of vitamin D on thyroid diseases.

27 November 2020 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
FPFlavia Prodam
Flavia Prodam
MCMarina Caputo
Marina Caputo
CMChiara Mele
Chiara Mele
PMPaolo Marzullo
Paolo Marzullo
Gianluca AimarettiGianluca Aimaretti
Gianluca Aimaretti